AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Cellectar Biosciences, Inc. Director's Dealing 2022

Apr 15, 2022

35021_dirs_2022-04-15_915ce3da-93a7-4272-ba8a-ce8a643f185a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3/A — Form 3/A

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2022-02-24

Reporting Person: Kolean Chad J (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	240	Direct

Footnotes

F1: This amendment to Form 3 is being filed to report the Reporting Person's direct ownership of 240 shares of Common Stock, which were inadvertently omitted from his Form 3 filed February 24, 2022.